适用于细针穿刺样本的DNA甲基化乳腺癌诊断模型的构建与验证OA
A DNA methylation-based diagnostic model for breast cancer using fine-needle aspiration specimens:development and validation
目的:构建乳腺癌相关的DNA甲基化诊断模型,并评估该模型在乳腺细针穿刺(FNA)细胞学样本中的诊断价值,为进一步开发辅助FNA诊断的经济可行的分子检测工具奠定基础.方法:回顾性收集98例乳腺福尔马林固定石蜡包埋(FFPE)组织样本作为训练集,209例乳腺FNA细胞学样本作为测试集.应用与下一代测序相结合的靶向甲基化测序方法,对FFPE样本中各甲基化位点的甲基化单倍型负荷(MHL)值进行权重分析,选取权重排序前20位的甲基化位点作为甲基化标志物.分别应用贝叶斯、随机森林和支持向量机3种机器学习算法构建乳腺癌诊断模型,以组织病理学诊断结果为金标准评价上述甲基化模型在FNA样本中的诊断效能.结果:通过FFPE样本筛选出了MHL权重最大的SOX17、CALN1、KDM4B、SND1、LINC01622等20个基因的DNA甲基化位点,并基于此构建了乳腺癌诊断模型.在FNA样本测试集中,以随机森林算法构建的诊断模型的受试者工作特征(ROC)曲线下面积(AUC)为 0.890[95%CI(0.833,0.948)],灵敏度为 100.00%[95%CI(97.25%,100.00%);136/136],特异度为 78.08%[95%CI(67.32%,86.03%);57/73],准确率为 92.34%[95%CI(87.93%,95.23%);193/209],阳性预测值为 89.47%[95%CI(83.59%,93.42%);136/152],阴性预测值为100.00%[95%CI(93.69%,100.00%);57/57],诊断效能显著优于贝叶斯(AUC=0.781)与支持向量机算法(AUC=0.740)(均为P<0.05).结论:基于SOX17、CALN1、KDM4B、SND1、LINC01622等基因的DNA甲基化特征,结合随机森林算法构建的乳腺癌诊断模型,在乳腺FNA样本中表现出优秀的诊断效能.
OBJECTIVE:To develop a DNA methylation-based diagnostic model for breast cancer and to evaluate its diagnostic performance in breast fine-needle aspiration(FNA)cytological specimens,thereby laying a foundation for development of an economically feasible molecular testing tool to aid in the diagnosis of FNA specimens.METHODS:This retrospective study utilized 98 formalin-fixed paraffin-embedded(FFPE)breast tissue specimens as the training cohort and 209 breast FNA cytological specimens as the test cohort.Targeted methylation sequencing using next-generation sequencing was performed.The methylation haplotype load(MHL)values of individual methylation loci in FFPE specimens were subjected to weighted analysis,and the loci with weight in the top 20 were selected as methylation biomarkers.Bayesian,random forest,and support vector machine(SVM)algorithms were applied to construct a diagnostic model for breast cancer.Histopathological diagnosis was used as the gold standard to evaluate diagnostic performance of the methylation model.RESULTS:In the FFPE specimens,20 methylation loci including SOX17,CALN1,KDM4B,SND1 and LINC01622,which had the largest weights in MHL,were selected to establish breast cancer diagnostic models.In the FNA testing cohort,the random forest based model achieved an area under the receiver operating characteristic curve(AUC)of 0.890[95%CI(0.833,0.948)],with a sensitivity of 100.00%[95%CI(97.25%,100.00%);136/136],a specificity of 78.08%[95%CI(67.32%,86.03%);57/73],an accuracy of 92.34%[95%CI(87.93%,95.23%);193/209],a positive predictive value of 89.47%[95%CI(83.59%,93.42%);136/152],and a negative predictive value of 100.00%[95%CI(93.69%,100.00%);57/57].The diagnostic performance of the random forest based model was significantly superior to that of the Bayesian(AUC=0.781)and SVM(AUC=0.740)based models(all P<0.05).CONCLUSION:A DNA methylation-based diagnostic model incorporating methylation features of genes such as SOX17,CALN1,KDM4B,SND1 and LINC01622,combined with a random forest algorithm,demonstrated excellent diagnostic performance in breast FNA specimens.
张彦祺;赵焕;张智慧;彭晓佳;梁心恩;李婷媛;吴泽妮;陈汶;郭会芹
国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院,病理科,北京 100021国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院,病理科,北京 100021国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院,病理科,北京 100021中国医学科学院北京协和医学院群医学及公共卫生学院,北京 100730国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院,病理科,北京 100021国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院,流行病室,北京 100021中国医学科学院北京协和医学院群医学及公共卫生学院,北京 100730国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院,流行病室,北京 100021国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院,病理科,北京 100021
医药卫生
乳腺癌细针穿刺DNA甲基化诊断模型诊断效能
breast cancerfine-needle aspirationDNA methylationdiagnostic modeldiagnostic performance
《癌变·畸变·突变》 2026 (3)
173-178,204,7
中央高水平医院临床科研业务费及中国癌症基金会北京希望马拉松专项基金(LC2022A24)国家自然科学基金(81972804)
评论